Please join us September 27 in San Carlos for a free seminar tackling two pressing topics affecting biotech and medical device companies: new accounting rules and managing foreign exchange risk.

New accounting rules are here—and more are coming
This year the Financial Accounting Standards Board introduced several new accounting rules that affect life sciences companies—and FASB has many more changes planned. Maureen Earley, a RoseRyan technical accounting guru, will review the practical implications and give you an inside look at what’s on deck.

International clinical trials bring foreign currency risks
Managing foreign currency exposure on international clinical trials is becoming increasingly important for life sciences companies. Nick Bennenbroek, a Wells Fargo economist and head of the bank’s currency strategy, will discuss where things are heading and how best to manage foreign exchange risk.

The program will be held 8–10 a.m. at Wells Fargo Insurance Services, 959 Skyway Road, San Carlos. It includes breakfast and time for networking.


Register here.

Need more information? Please contact Eve Murto.